Related references
Note: Only part of the references are listed.Prognostic value of PD-L1 expression in bronchopulmonary neuroendocrine tumours
Erik Rosner et al.
ENDOCRINE CONNECTIONS (2021)
The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
Nan Han et al.
CELLS (2021)
GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma
Yu-an Qiu et al.
FRONTIERS IN ONCOLOGY (2021)
Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes
Geetanjali Sharma et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis
Marianna Talia et al.
CELLS (2020)
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
Julia Tutzauer et al.
PLOS ONE (2020)
Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells
Danning Shi et al.
BMC PHARMACOLOGY & TOXICOLOGY (2020)
Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma
Christopher A. Natale et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival
Susanne Schueler-Toprak et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Neuroendocrine neoplasms of lung, pancreas and gut: a morphology-based comparison
Atsuko Kasajima et al.
ENDOCRINE-RELATED CANCER (2020)
Human G protein-coupled receptor 30 is N-glycosylated and N-terminal domain asparagine 44 is required for receptor structure and activity
Ernesto Gonzalez de Valdivia et al.
BIOSCIENCE REPORTS (2019)
Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer
Shan Tian et al.
MEDICAL SCIENCE MONITOR (2019)
Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status
Shuang Ye et al.
ENDOCRINE CONNECTIONS (2019)
Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody
Markus Herzig et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes
Saireudee Chaturantabut et al.
GASTROENTEROLOGY (2019)
G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer
Seon-Jin Lee et al.
BMB REPORTS (2019)
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin
Rebekka Mai et al.
SCIENTIFIC REPORTS (2019)
Roles of G protein-coupled estrogen receptor GPER in metabolic regulation
Geetanjali Sharma et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients
Stewart G. Martin et al.
Oncotarget (2018)
A Series of Indole-Thiazole Derivatives Act as GPER Agonists and Inhibit Breast Cancer Cell Growth
Austin O'Dea et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression
Taishi Akimoto et al.
NEOPLASIA (2018)
GPER/ERK&B pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells
Ping Zhu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
Qiao Liu et al.
MOLECULAR CANCER (2017)
Association of a reduction of G-protein coupled receptor 30 expression and the pathogenesis of preeclampsia
Xiang Feng et al.
MOLECULAR MEDICINE REPORTS (2017)
Pharmacological chaperone approaches for rescuing GPCR mutants: Current state, challenges, and screening strategies
Pieter Beerepoot et al.
PHARMACOLOGICAL RESEARCH (2017)
Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas
Daniel Kaemmerer et al.
ONCOTARGET (2017)
Cardiomyocyte-specific deletion of the G protein-coupled estrogen receptor (GPER) leads to left ventricular dysfunction and adverse remodeling: A sex-specific gene profiling analysis
Hao Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Identification of the G protein-coupled estrogen receptor (GPER) in human prostate: expression site of the estrogen receptor in the benign and neoplastic gland
V. Rago et al.
ANDROLOGY (2016)
G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis
Tao Wei et al.
CANCER LETTERS (2016)
Activation of G-Protein-Coupled Estrogen Receptor Inhibits the Migration of Human Nonsmall Cell Lung Cancer Cells via IKK-β/NF-κB Signals
Guangfa Zhu et al.
DNA AND CELL BIOLOGY (2016)
Effects of Atrazine on Estrogen Receptor α- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts
Lidia Albanito et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2015)
Somatostatin Receptors in Bronchopulmonary Neuroendocrine Neoplasms: New Diagnostic, Prognostic, and Therapeutic Markers
Daniel Kaemmerer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Estrogen regulates Hippo signaling via GPER in breast cancer
Xin Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17 beta-estradiol (E-2) and selective agonist G1
Changyu Liu et al.
MEDICAL ONCOLOGY (2015)
Emerging roles of GPER in diabetes and atherosclerosis
Matthias Barton et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
Daniel Kaemmerer et al.
ONCOTARGET (2015)
International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators
Eric R. Prossnitz et al.
PHARMACOLOGICAL REVIEWS (2015)
Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol
Rainer Girgert et al.
BMC CANCER (2014)
A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells
Huidi Liu et al.
CELL BIOLOGY INTERNATIONAL (2014)
The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors
Sabine Heublein et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
GPER functions as a tumor suppressor in triple-negative breast cancer cells
Christine Weissenborn et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
The G Protein-Coupled Estrogen Receptor (GPER) Is Expressed in Two Different Subcellular Localizations Reflecting Distinct Tumor Properties in Breast Cancer
Eleftherios P. Samartzis et al.
PLOS ONE (2014)
Using pharmacological chaperones to restore proteostasis
Ya-Juan Wang et al.
PHARMACOLOGICAL RESEARCH (2014)
Pharmacological chaperoning: A primer on mechanism and pharmacology
Nancy J. Leidenheimer et al.
PHARMACOLOGICAL RESEARCH (2014)
Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling
Sarah H. Lindsey et al.
STEROIDS (2014)
The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo
W. Wei et al.
CELL DEATH & DISEASE (2014)
Expression of the oestrogen receptor GPER by testicular peritubular cells is linked to sexual maturation and male fertility
F. Sandner et al.
ANDROLOGY (2014)
Resveratrol inhibits Kv2.2 currents through the estrogen receptor GPR30-mediated PKC pathway
Wen-Hao Dong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
GPER-1 Expression Decreases During Breast Cancer Tumorigenesis
Tanja Ignatov et al.
CANCER INVESTIGATION (2013)
GPER Deficiency in Male Mice Results in Insulin Resistance, Dyslipidemia, and a Proinflammatory State
Geetanjali Sharma et al.
ENDOCRINOLOGY (2013)
Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor a (ERα)
Chia-Lung Tsai et al.
PLOS ONE (2013)
G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines
Maciej Skrzypczak et al.
STEROIDS (2013)
GPER-1 acts as a tumor suppressor in ovarian cancer
Tanja Ignatov et al.
JOURNAL OF OVARIAN RESEARCH (2013)
G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth
Whitney K. Petrie et al.
OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2013)
Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer
Venkatakrishna Rao Jala et al.
BMC CANCER (2012)
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
C. Krakstad et al.
BRITISH JOURNAL OF CANCER (2012)
GPR30, the Non-Classical Membrane G Protein Related Estrogen Receptor, Is Overexpressed in Human Seminoma and Promotes Seminoma Cell Proliferation
Nicolas Chevalier et al.
PLOS ONE (2012)
The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
Zuzana Kolkova et al.
JOURNAL OF OVARIAN RESEARCH (2012)
Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle
Xuan Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study
George Pentheroudakis et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Estrogen Receptor GPR30 Reduces Oxidative Stress and Proteinuria in the Salt-Sensitive Female mRen2.Lewis Rat
Sarah H. Lindsey et al.
HYPERTENSION (2011)
G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables
Hao-jun Luo et al.
JOURNAL OF BREAST CANCER (2011)
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity
Megan K. Dennis et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes
Vittoria Rago et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest
Q. K. Y. Chan et al.
CELL DEATH AND DIFFERENTIATION (2010)
Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice
Alexander Balhuizen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
GPR30 Does Not Mediate Estrogenic Responses in Reproductive Organs in Mice
Christiane Otto et al.
BIOLOGY OF REPRODUCTION (2009)
Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation
Benjamin C. Lin et al.
CANCER RESEARCH (2009)
Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway
Yin-Yan He et al.
CANCER SCIENCE (2009)
Regulatory Role of G Protein-Coupled Estrogen Receptor for Vascular Function and Obesity
Elvira Haas et al.
CIRCULATION RESEARCH (2009)
Expression Pattern of G Protein-Coupled Receptor 30 in LacZ Reporter Mice
Joerg Isensee et al.
ENDOCRINOLOGY (2009)
Deletion of the G Protein-Coupled Receptor 30 Impairs Glucose Tolerance, Reduces Bone Growth, Increases Blood Pressure, and Eliminates Estradiol-Stimulated Insulin Release in Female Mice
Ulrika E. A. Martensson et al.
ENDOCRINOLOGY (2009)
GPR30 predicts poor survival for ovarian cancer
Harriet O. Smith et al.
GYNECOLOGIC ONCOLOGY (2009)
Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues
Georgina G. J. Hazell et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Mechanisms of estrogen signaling and gene expression via GPR30
Eric R. Prossnitz et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
In vivo effects of a GPR30 antagonist
Megan K. Dennis et al.
NATURE CHEMICAL BIOLOGY (2009)
The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone
Terhi J. Heino et al.
JOURNAL OF ENDOCRINOLOGY (2008)
GPR30 estrogen receptor expression in the growth plate declines as puberty progresses
Andrei S. Chagin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30
Chetana M. Revankar et al.
ACS CHEMICAL BIOLOGY (2007)
Identification and developmental changes of aromatase and estrogen receptor expression in prepubertal and pubertal human adrenal tissues
Maria Sonia Baquedano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
GPR30: a novel indicator of poor survival for endometrial carcinoma
Harriet O. Smith et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells
Lidia Albanito et al.
CANCER RESEARCH (2007)
Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression
Edward J. Filardo et al.
CLINICAL CANCER RESEARCH (2006)
17β-Estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30
Adele Vivacqua et al.
MOLECULAR PHARMACOLOGY (2006)
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1
O Sukocheva et al.
JOURNAL OF CELL BIOLOGY (2006)
Virtual and biomolecular screening converge on a selective agonist for GPR30
CG Bologa et al.
NATURE CHEMICAL BIOLOGY (2006)
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
CM Revankar et al.
SCIENCE (2005)
Pharmacological chaperone action on G-protein-coupled receptors
V Bernier et al.
CURRENT OPINION IN PHARMACOLOGY (2004)
Somatostatin receptor subtypes in human pheochromocytoma: Subcellular expression pattern and functional relevance for octreotide scintigraphy
J Mundschenk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Share Paper
